Sicca syndrome in systemic sclerosis: a narrative review on a neglected issue.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
06 02 2023
Historique:
received: 12 02 2022
revised: 25 06 2022
accepted: 28 06 2022
pubmed: 23 7 2022
medline: 8 2 2023
entrez: 22 7 2022
Statut: ppublish

Résumé

SSc is an auto-immune disease characterized by life-threatening manifestations such as lung fibrosis or pulmonary arterial hypertension. Symptoms with a detrimental impact on quality of life are also reported and sicca syndrome (xerostomia, xeropthalmia) is present in up to 80% of patients with SSc. Sicca syndrome can occur in the absence of overlap with Sjögren's disease and recent studies highlight that fibrosis of minor and major salivary glands, directly linked to the pathogenesis of SSc, could be a major contributor of xerostomia in SSc. This narrative review provides an overview of the clinical presentation, diagnostic strategies, management and future perspectives on sicca syndrome in patients with SSc.

Identifiants

pubmed: 35866609
pii: 6648344
doi: 10.1093/rheumatology/keac412
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

SI1-SI11

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

François Zimmermann (F)

Department of Internal Medicine.

François Robin (F)

Department of Rheumatology, CHU Rennes, University of Rennes 1.
Department of Rheumatology, Rennes University Hospital, University Rennes; Inserm UMR 1241, Inra, Institut NUMECAN (Nutrition Metabolisms and Cancer), University Rennes.

Leila Caillault (L)

Department of Internal Medicine.

Claire Cazalets (C)

Department of Internal Medicine.

Francisco Llamas-Gutierrez (F)

Department of Anatomopathology, CHU Rennes, University of Rennes 1.

Ronan Garlantézec (R)

Département de Santé Publique, CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), UMR_S 1085, Rennes.

Sandrine Jousse-Joulin (S)

Rheumatology Department, CHU de Brest, Univ Brest, Inserm, LBAI, UMR1227, Brest.

Elisabeth Diot (E)

Department of Internal Medicine, CHRU Tours, Tours.

Sami Eric Mensi (SE)

Department of Internal Medicine.

Nicolas Belhomme (N)

Department of Internal Medicine.

Patrick Jégo (P)

Department of Internal Medicine.
Département de Santé Publique, CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), UMR_S 1085, Rennes.

Guillaume Coiffier (G)

Department of Internal Medicine.
Department of Rheumatology, CH Dinan, Dinan, France.

Alain Lescoat (A)

Department of Internal Medicine.
Département de Santé Publique, CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), UMR_S 1085, Rennes.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH